These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 5882062

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The action of tetranicotinoylfructose in peripheral vascular disease.
    Andrews G, Judge TG, Walkey F.
    Practitioner; 1973 Jul; 211(261):83-5. PubMed ID: 4580277
    [No Abstract] [Full Text] [Related]

  • 4. [Effect of cardilan on blood flow disorders in the extremities].
    Zapalski S, Ciszewski A.
    Pol Tyg Lek; 1970 Aug 10; 25(32):1218-20. PubMed ID: 5472553
    [No Abstract] [Full Text] [Related]

  • 5. [Cardilan in the treatment of obliterative diseases of peripheral arteries].
    Ginko T, Adamczyk R, Dyaczyńska A.
    Wiad Lek; 1971 Jun 15; 24(12):1211-5. PubMed ID: 5561279
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [The influence of nicotinic acid on circulatory disorders of the lower extremities].
    Kirsch J, Kirsch J.
    Landarzt; 1964 Dec 20; 40(35):1527-30. PubMed ID: 5826399
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [On prolonged hemokinetic therapy of occlusive arterial diseases].
    Alegría A.
    Med Klin; 1965 Jul 09; 60(28):1126-31. PubMed ID: 5835983
    [No Abstract] [Full Text] [Related]

  • 10. [The action of xanthinol nicotinate on the peripheral circulation of the aged].
    Chevat H, Steenhouwer B, Hiltenbrand C, Legrand MF, Graux P.
    Angeiologie; 1968 Jul 09; 20(2):33-42. PubMed ID: 5682235
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Nicotinic acid plasma concentrations after ingestion of 1,3,4,6-tetranicotinoyl-fructo-furanose (tetranicotinoylfructose, nicofuranose).
    Salmi HA, Frey H.
    Curr Ther Res Clin Exp; 1974 Jun 09; 16(6):669-74. PubMed ID: 4211148
    [No Abstract] [Full Text] [Related]

  • 14. [Treatment of peripheral circulatory disorders with a nicotinic acid derivative].
    Kienholz E.
    Med Klin; 1965 Aug 13; 60(33):1321-4. PubMed ID: 5843335
    [No Abstract] [Full Text] [Related]

  • 15. [Use of a xanthine derivative in peripheral arterial blood flow disorders].
    de Weger WP.
    Med Monatsschr; 1970 May 13; 24(5):221-5. PubMed ID: 5512478
    [No Abstract] [Full Text] [Related]

  • 16. [Compensation grade of arterial occlusions and action of intravenously administered vasoactive drugs].
    Bollinger A, Lüthy E.
    Helv Med Acta Suppl; 1967 May 28; 47():128. PubMed ID: 5286297
    [No Abstract] [Full Text] [Related]

  • 17. [Clinical trials with xanthinol niacinate in angiological therapy].
    García Zozaya R.
    Rev Clin Esp; 1966 Mar 15; 100(5):347-53. PubMed ID: 5937752
    [No Abstract] [Full Text] [Related]

  • 18. [Effect of complamin on the disturbances of peripheral circulation in the light of rheoangiographic studies and measurement of skin temperature].
    Dryjski J, Wesolowski J.
    Pol Tyg Lek; 1966 Dec 12; 21(50):1928-30. PubMed ID: 5979808
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.